Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The genetic structure of SARS‐CoV‐2 does not rule out a laboratory origin
Rossana Segreto, Yuri Deigin
BioEssays (2020) Vol. 43, Iss. 3
Open Access | Times Cited: 107

Showing 26-50 of 107 citing articles:

Tracing the origin of Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2): A systematic review and narrative synthesis
Nagendra Thakur, Sayak Das, Swatantra Kumar, et al.
Journal of Medical Virology (2022) Vol. 94, Iss. 12, pp. 5766-5779
Open Access | Times Cited: 12
SARS-CoV-2 evolution has increased resistance to monoclonal antibodies and first-generation COVID-19 vaccines: Is there a future therapeutic role for soluble ACE2 receptors for COVID-19?
Rohan Ameratunga, A. M. Jordan, Klaus Lehnert, et al.
Antiviral Research (2024) Vol. 227, pp. 105894-105894
Closed Access | Times Cited: 2
Retrouver les origines du SARS-CoV-2 dans les phylogénies de coronavirus
Erwan Sallard, José Halloy, Didier Casañe, et al.
médecine/sciences (2020) Vol. 36, Iss. 8-9, pp. 783-796
Open Access | Times Cited: 17
Common Variable Immunodeficiency Disorders as a Model for Assessing COVID-19 Vaccine Responses in Immunocompromised Patients
Rohan Ameratunga, See‐Tarn Woon, Richard Steele, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 10
People’s understanding of the concept of misinformation
Magda Osman, Zoë Adams, Björn Meder, et al.
Journal of Risk Research (2022) Vol. 25, Iss. 10, pp. 1239-1258
Open Access | Times Cited: 10
SARS-CoV-2 the ASIA virus (Autoimmune/autoinflammatory Syndrome Induced by Adjuvants), the risk of infertility and vaccine hesitancy
Rohan Ameratunga
Expert Review of Vaccines (2022) Vol. 21, Iss. 9, pp. 1177-1184
Closed Access | Times Cited: 10
Global Catastrophic Biological Risks in the Post-COVID-19 World: Time to Act Is Now
Manousos E. Kambouris
OMICS A Journal of Integrative Biology (2023) Vol. 27, Iss. 4, pp. 153-170
Closed Access | Times Cited: 6
<b>SARS-CoV-2 and the Secret of the Furin Site</b>
Antonio R. Romeu, Enric Ollé
(2021)
Open Access | Times Cited: 14
SARS-CoV-2 in brief: from virus to prevention
Hassan Karami, Zeinab Karimi, Negin Karami
Osong Public Health and Research Perspectives (2022) Vol. 13, Iss. 6, pp. 394-406
Open Access | Times Cited: 10
SARS-CoV-2 gained a novel spike protein S1–N-Terminal Domain (S1-NTD)
Perumal Arumugam Desingu, K. Nagarajan, Kuldeep Dhama
Environmental Research (2022) Vol. 211, pp. 113047-113047
Open Access | Times Cited: 9
Leak or Leap? Evidence and Cognition Surrounding the Origins of the SARS-CoV-2 Virus
Stephan Lewandowsky, Peter Jacobs, Stuart J. D. Neil
Routledge eBooks (2023), pp. 26-39
Open Access | Times Cited: 5
Environmentally-induced mdig contributes to the severity of COVID-19 through fostering expression of SARS-CoV-2 receptor NRPs and glycan metabolism
Qian Zhang, Priya Wadgaonkar, Liping Xu, et al.
Theranostics (2021) Vol. 11, Iss. 16, pp. 7970-7983
Open Access | Times Cited: 12
The future of biotechnology crime: A parallel Delphi study with non-traditional experts
Mariam Elgabry, Darren Nesbeth, Shane D. Johnson
Futures (2022) Vol. 141, pp. 102970-102970
Open Access | Times Cited: 8
Selective IgA Deficiency May Be an Underrecognized Risk Factor for Severe COVID-19
Rohan Ameratunga, Euphemia Leung, See‐Tarn Woon, et al.
The Journal of Allergy and Clinical Immunology In Practice (2022) Vol. 11, Iss. 1, pp. 181-186
Open Access | Times Cited: 8
Why It Remains Statistically Probable That SARS-CoV-2 Was Isolated and Then Accidentally Lab-Leaked before the First COVID-19 Outbreak
Theodor-Nicolae Carp
(2024)
Open Access | Times Cited: 1
There is no evidence of SARS‐CoV‐2 laboratory origin: Response to Segreto and Deigin (DOI: 10.1002/bies.202000240)
Alexander Tyshkovskiy, Alexander Y. Panchin
BioEssays (2021) Vol. 43, Iss. 5
Open Access | Times Cited: 8
Conserved molecular signatures in the spike protein provide evidence indicating the origin of SARS-CoV-2 and a Pangolin-CoV (MP789) by recombination(s) between specific lineages of Sarbecoviruses
Bijendra Khadka, Radhey S. Gupta
PeerJ (2021) Vol. 9, pp. e12434-e12434
Open Access | Times Cited: 8
Analyses of Long-Term Epidemic Trends and Evolution Characteristics of Haplotype Subtypes Reveal the Dynamic Selection on SARS-CoV-2
Binbin Xi, Yuhuan Meng, Dawei Jiang, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 454-454
Open Access | Times Cited: 5
Molecular Biology Clues Portray SARS-CoV-2 as a Gain-of-Function Laboratory Manipulation of Bat CoV RaTG13
Ariel Fernández
ACS Medicinal Chemistry Letters (2021) Vol. 12, Iss. 6, pp. 941-942
Open Access | Times Cited: 6
On-going evidence on SARS-CoV-2 furin site arginine codon usage bias and new found PRRA-like insertions
Antonio R. Romeu
Research Square (Research Square) (2023)
Open Access | Times Cited: 2
Reviewing Findings on the Polypeptide Sequence of the SARS-CoV-2 S-Protein to Discuss the Origins of the Virus
Alberto Maria Cattaneo
Future Virology (2022) Vol. 17, Iss. 6, pp. 393-402
Open Access | Times Cited: 4
COVID-19 in animals: A need for One Health approach
Harini Ramanujam, Kannan Palaniyandi
Indian Journal of Medical Microbiology (2022) Vol. 40, Iss. 4, pp. 485-491
Open Access | Times Cited: 4
Non-uniform aspects of the SARS-CoV-2 intraspecies evolution reopen question of its origin
Sk. Sarif Hassan, Vaishnavi Kodakandla, Elrashdy M. Redwan, et al.
International Journal of Biological Macromolecules (2022) Vol. 222, pp. 972-993
Open Access | Times Cited: 4
Critical role of diagnostic SARS-CoV-2 T cell assays for immunodeficient patients
Rohan Ameratunga, See‐Tarn Woon, Richard Steele, et al.
Journal of Clinical Pathology (2022) Vol. 75, Iss. 12, pp. 793-797
Closed Access | Times Cited: 4
The genetic structure of SARS‐CoV‐2 is consistent with both natural or laboratory origin: Response to Tyshkovskiy and Panchin (10.1002/bies.202000325)
Yuri Deigin, Rossana Segreto
BioEssays (2021) Vol. 43, Iss. 9
Closed Access | Times Cited: 5

Scroll to top